Company intelligence / Profile preview
ImmunSYS, Inc.
Fort Lauderdale, Florida, United Statesimmunsys.com ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Phase 1
01
Overview
ImmunSYS, Inc. develops innovative intratumoral immunotherapies for late-stage metastatic prostate cancer and other solid tumors using its proprietary YourVaccx™ platform. The approach combines a novel energy delivery device with a multi-component drug regimen to stimulate the immune system to attack cancer throughout the body. The technology was developed by Dr. Gary Onik—who also benefited as a patient—and has shown promising results in initial applications.[1][2]
- Therapeutic areas
- Oncology
- Modalities
- Intratumoral immunotherapy (YourVaccx™ platform)Combination immunotherapeutic drugs[1][4]Controlled cell lysis[1]Device-based therapy (ANTIGENerator™ energy delivery device)[4]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on ImmunSYS, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ImmunSYS, Inc..